InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-11.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Namouni Fouad, Président et Directeur de la Recherche et Développement. Insider active across 2 companies, notably Aprea Therapeutics, Inc.. In total, 15 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €2.3m. Activity tracked since 30 June 2021. The latest transaction was disclosed on 5 March 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations15 total
6,489 shares@ US$88.8023.7% of flowCommon StockSEC:0001415889-25-007402:0
13,200 shares0Common StockSEC:0001415889-25-006602:0
3,633 shares@ US$89.3212.8% of flowCommon StockSEC:0001415889-24-024776:0
4,377 shares@ US$90.6915.9% of flowCommon StockSEC:0001415889-24-007554:0
15,000 shares0Common StockSEC:0001415889-24-007021:0
3,769 shares@ US$48.067.5% of flowCommon StockSEC:0001415889-23-014022:0
1,885 shares@ US$45.723.5% of flowCommon StockSEC:0001415889-23-004564:0
15,000 shares0Common StockSEC:0001415889-23-004262:0
3,477 shares@ US$67.3010.2% of flowCommon StockSEC:0001415889-22-010366:0
1,047 shares@ US$56.199.0% of flowCommon StockSEC:0001415889-22-002738:0
15,000 shares0Common StockSEC:0001415889-22-002432:0
3,241 shares@ US$98.1845.5% of flowCommon StockSEC:0001179110-21-009297:0
3,241 shares@ US$98.1812.0% of flowCommon StockSEC:0001179110-21-009297
4,610 shares0Common StockSEC:0001567619-21-012871
4,610 shares0Common StockSEC:0001567619-21-012871:0
15 of 15 declarations
About Namouni Fouad
Fouad Namouni is the Director, President of R & D at Aprea Therapeutics, Inc. and Blueprint Medicines Corp. He oversees research and development initiatives, playing a key role in innovation and the development of new products.
